NCT06477458 Deep Learning for Preoperative Pulmonary Assessment in Thoracic CT
| NCT ID | NCT06477458 |
| Status | Recruiting |
| Phase | — |
| Sponsor | The First Affiliated Hospital of Guangzhou Medical University |
| Condition | Elective Thoracic Surgery |
| Study Type | OBSERVATIONAL |
| Enrollment | 2,000 participants |
| Start Date | 2023-10-01 |
| Primary Completion | 2024-09-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 2,000 participants in total. It began in 2023-10-01 with a primary completion date of 2024-09-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The trial was designed as a single-centre, non-interventional prospective observational study to utilize deep learning technology combined with computed tomography (CT) images to precisely predict the pulmonary function indicators of thoracic surgery preoperative patients.
Eligibility Criteria
Inclusion Criteria: * (1) Signing of the informed consent form; * (2) Male or female, aged 18-75 years; * (3) Undergoing elective thoracic surgery; * (4) Good preoperative pulmonary function cooperation and complete reporting; * (5) Preoperative chest single/dual phase CT scans without significant artefacts and with complete imaging; * (6) The interval between preoperative pulmonary function and single/dual phase CT scans does not exceed one month. Exclusion Criteria: * (1) Poor preoperative pulmonary function cooperation or missing reports; * (2) Preoperative chest single/dual phase CT scans exhibit significant artefacts or image omission; * (3) The interval between preoperative pulmonary function and single/dual phase CT scans exceeds one month; * (4) Complication with severe respiratory disorders (such as lung transplantation, pneumothorax, giant bullae, etc.); * (5) Coexisting with other severe functional impairments; * (6) Patients with obstructive lesions such as airway or esophageal stenosis; * (7) Height beyond the predicted equation range (Female \< 1.45m; Male \< 1.55m); * (8) Medication use before pulmonary function testing that does not meet the cessation guidelines; * (9) Pulmonary function report quality graded D-F.
Contact & Investigator
Jianxing He, MD
PRINCIPAL INVESTIGATOR
Department of Cardiothoracic Surgery, the First Affiliated Hospital of Guangzhou Medical College
Frequently Asked Questions
Who can join the NCT06477458 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 75 Years, studying Elective Thoracic Surgery. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06477458 currently recruiting?
Yes, NCT06477458 is actively recruiting participants. Contact the research team at drjianxing.he@gmail.com for enrollment information.
Where is the NCT06477458 trial being conducted?
This trial is being conducted at Guangzhou, China.
Who is sponsoring the NCT06477458 clinical trial?
NCT06477458 is sponsored by The First Affiliated Hospital of Guangzhou Medical University. The principal investigator is Jianxing He, MD at Department of Cardiothoracic Surgery, the First Affiliated Hospital of Guangzhou Medical College. The trial plans to enroll 2,000 participants.